RxDoctor Payments Data

Robert Marchand, MD

Orthopaedic Surgery · Wakefield, RINPI 1881658896

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,334,563 of the $1,416,363 with a category attached, or 94.2%. Stryker accounts for 100.0% of it on its own, with 7 other manufacturers making up the rest. Among orthopaedic surgery clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,416,363in general payments, 2019–2025

Across 918 payments — averaging $1542.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$1.4M
  • Orthosensor Inc.$369
  • Engage Uni, LLC$114
  • Pacira Pharmaceuticals Incorporated$50
  • Vertex$32
  • Teleflex LLC$30
  • plus $49 from 2 others
$889,744in research payments, 2019–2025

Across 69 payments — averaging $12,895 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$890K

What the payments were for

  • Consulting fees$1,334,56394%
  • Travel & lodging$74,0435%
  • Food & beverage$7,6441%
  • Gifts$1140%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker907$1,415,720
Orthosensor Inc.3$369
Engage Uni, LLC1$114
Pacira Pharmaceuticals Incorporated3$50
Vertex1$32
Teleflex LLC1$30
Bioventus LLC1$27
Acera Surgical, Inc.1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,416,363 in reported general payments places this provider in the 95th percentile of 124 orthopaedic surgery providers in Rhode Island.

See all orthopaedic surgery providers in Rhode Island

Medicare billing

Part B allowed, 2024
$363,679
Medicare patients
250
Services billed
1,097

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tranexamic Acid442$2,325
Meloxicam465$658
Omeprazole419$414
Amoxicillin136$301
Mupirocin39$301
Clindamycin Hcl16$63

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Wakefield

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →